Immunosuppression in myelo-and lymphoproliferative disorders.
Papa
G
G
Cattedra di Ematologia, Università Tor Vergata, Ospedale S. Eugenio, Roma, Italy.
Cudillo
L
L
Rainaldi
A
A
Dentamaro
T
T
D000328:Adult; D000583:Amikacin / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D002443:Ceftriaxone / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007938:Leukemia / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D017334:Teicoplanin / Q000627:therapeutic use
D017334:Teicoplanin; D002443:Ceftriaxone; D000583:Amikacin